药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfacytine
Aclidinium
Aclidinium may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Peginesatide
Peginesatide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Ruxolitinib
Ruxolitinib may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Deferiprone
Deferiprone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Tiopronin
Tiopronin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Plerixafor
Plerixafor may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Methylnaltrexone
Methylnaltrexone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Dimercaprol
Dimercaprol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Gadofosveset trisodium
Gadofosveset trisodium may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Desvenlafaxine
Desvenlafaxine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Flupirtine
Flupirtine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Telavancin
Telavancin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Nalmefene
Nalmefene may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Prasugrel
Prasugrel may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Icatibant
Icatibant may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Ipilimumab
Ipilimumab may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Pentaerythritol tetranitrate
Pentaerythritol tetranitrate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Brivaracetam
Brivaracetam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Migalastat
Migalastat may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Ezogabine
Ezogabine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.